Association of Echocardiographic Left Ventricular End-Systolic Volume and Volume-Derived Ejection Fraction With Outcome in Asymptomatic Chronic Aortic Regurgitation.

Abstract:

Importance:Volumetric measurements by transthoracic echocardiogram may better reflect left ventricular (LV) remodeling than conventional linear LV dimensions. However, the association of LV volumes with mortality in patients with chronic hemodynamically significant aortic regurgitation (AR) is unknown. Objective:To assess whether LV volumes and volume-derived LV ejection fraction (Vol-LVEF) are determinants of mortality in AR. Design, Setting, and Participants:This cohort study included consecutive asymptomatic patients with chronic moderately severe to severe AR from a tertiary referral center (January 2004 through April 2019). Exposures:Clinical and echocardiographic data were analyzed retrospectively. Aortic regurgitation severity was graded by comprehensive integrated approach. De novo disk-summation method was used to derive LV volumes and Vol-LVEF. Main Outcome and Measures:Associations between all-cause mortality under medical surveillance and the following LV indexes: linear LV end-systolic dimension index (LVESDi), linear LVEF, LV end-systolic volume index (LVESVi), and Vol-LVEF. Results:Of 492 asymptomatic patients (mean [SD] age, 60 [17] years; 425 men [86%]), ischemic heart disease prevalence was low (41 [9%]), and 453 (92.1%) had preserved linear LVEF (≥50%) with mean (SD) LVESVi of 41 (15) mL/m2. At a median (interquartile range) of 5.4 (2.5-10.1) years, 66 patients (13.4%) died under medical surveillance; overall survival was not different than the age- and sex-matched general population (P = .55). Separate multivariate models, adjusted for age, sex, Charlson Comorbidity Index, and AR severity, demonstrated that in addition to linear LVEF and LVESDi, LVESVi and Vol-LVEF were independently associated with mortality under surveillance (all P < .046) with similar C statistics (range, 0.83-0.84). Spline curves showed that continuous risks of death started to rise for both linear LVEF and Vol-LVEF less than 60%, LVESVi more than 40 to 45 mL/m2, and LVESDi above 21 to 22 mm/m2. As dichotomized variables, patients with LVESVi more than 45 mL/m2 exhibited increased relative death risk (hazard ratio, 1.93; 95% CI, 1.10-3.38; P = .02) while LVESDi more than 20 mm/m2 did not (P = .32). LVESVi more than 45 mL/m2 showed a decreased survival trend compared with expected population survival. Conclusions and Relevance:In this large asymptomatic cohort of patients with hemodynamically significant AR, LVESVi and Vol-LVEF worked equally as well as LVESDi and linear LVEF in risk discriminating patients with excess mortality. A LVESVi threshold of 45 mL/m2 or greater was significantly associated with an increased mortality risk.

journal_name

JAMA Cardiol

journal_title

JAMA cardiology

authors

Yang LT,Anand V,Zambito EI,Pellikka PA,Scott CG,Thapa P,Padang R,Takeuchi M,Nishimura RA,Enriquez-Sarano M,Michelena HI

doi

10.1001/jamacardio.2020.5268

subject

Has Abstract

pub_date

2020-11-04 00:00:00

eissn

2380-6583

issn

2380-6591

pii

2772324

pub_type

杂志文章
  • Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.

    abstract:Importance:Quality of percutaneous coronary intervention (PCI) is commonly assessed by risk-adjusted mortality. However, this metric may result in procedural risk aversion, especially for high-risk patients. Objective:To determine correlation and reclassification between hospital-level disease-specific mortality and P...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2020.0753

    authors: Nathan AS,Xiang Q,Wojdyla D,Khatana SAM,Dayoub EJ,Wadhera RK,Bhatt DL,Kolansky DM,Kirtane AJ,Rao SV,Yeh RW,Groeneveld PW,Wang TY,Giri J

    更新日期:2020-07-01 00:00:00

  • Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment.

    abstract:Importance:The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated the benefit of lowering systolic blood pressure (SBP) to 120 mm Hg, yet other trials, such as Heart Outcomes Prevention Evaluation-3 (HOPE-3), did not find consistent benefit. How to incorporate these results into the treatment of those wit...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.2861

    authors: Navar AM,Pencina MJ,Peterson ED

    更新日期:2016-11-01 00:00:00

  • Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice: An NCDR Registry to Practice Project.

    abstract:Importance:Physicians have been criticized for having an overly enthusiastic response to new device approvals, especially for novel technologies. However, to our knowledge, the rates of new product adoption and patterns of new device usage in clinical practice have not been well described. Objective:To characterize th...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.0388

    authors: Chau KH,Kennedy KF,Messenger JC,Garratt KN,Maddox TM,Yeh RW,Kirtane AJ

    更新日期:2019-06-01 00:00:00

  • Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure.

    abstract:Importance:Medicare Advantage (MA), a private insurance plan option, now covers one-third of all Medicare beneficiaries. Although patients with cardiovascular disease enrolled in MA have been reported to receive higher quality of care in the ambulatory setting than patients enrolled in fee-for-service (FFS) Medicare, i...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.3638

    authors: Figueroa JF,Wadhera RK,Frakt AB,Fonarow GC,Heidenreich PA,Xu H,Lytle B,DeVore AD,Matsouaka R,Yancy CW,Bhatt DL,Joynt Maddox KE

    更新日期:2020-09-02 00:00:00

  • Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.

    abstract:Importance:Bioresorbable scaffolds were designed to provide clinical benefits after their complete bioresorption. Prior studies demonstrated early risks with the Absorb polymeric bioresorbable vascular scaffold (BVS). Whether this risk profile changes over time during the course of its bioresorption is unknown. Object...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,meta分析

    doi:10.1001/jamacardio.2019.4101

    authors: Stone GW,Kimura T,Gao R,Kereiakes DJ,Ellis SG,Onuma Y,Chevalier B,Simonton C,Dressler O,Crowley A,Ali ZA,Serruys PW

    更新日期:2019-12-01 00:00:00

  • Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of Evolocumab.

    abstract:Importance:Levels of proprotein convertase subtilisin kexin type 9 (PCSK9) vary markedly across the population and are influenced by genetic and nongenetic factors. Evolocumab is a fully human, monoclonal antibody against PCSK9 that reduces low-density lipoprotein cholesterol (LDL-C) levels by 55% to 75%. Whether the e...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.5395

    authors: Desai NR,Giugliano RP,Wasserman SM,Gibbs JP,Liu T,Scott R,Sabatine MS

    更新日期:2017-05-01 00:00:00

  • Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.

    abstract:Importance:Transthyretin cardiac amyloidosis (also known as ATTR cardiac amyloidosis) is an increasingly recognized cause of heart failure with preserved ejection fraction. In single-center studies, technetium 99m pyrophosphate (Tc 99m PYP) cardiac imaging noninvasively detects ATTR cardiac amyloidosis, but the accurac...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2016.2839

    authors: Castano A,Haq M,Narotsky DL,Goldsmith J,Weinberg RL,Morgenstern R,Pozniakoff T,Ruberg FL,Miller EJ,Berk JL,Dispenzieri A,Grogan M,Johnson G,Bokhari S,Maurer MS

    更新日期:2016-11-01 00:00:00

  • Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.

    abstract:Importance:In clinical trials, transcatheter aortic valve replacement (TAVR) has been shown to improve symptoms and quality of life. As this technology moves into general clinical practice, evaluation of the health status outcomes among unselected patients treated with TAVR is of critical importance. Objective:To exam...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2016.5302

    authors: Arnold SV,Spertus JA,Vemulapalli S,Li Z,Matsouaka RA,Baron SJ,Vora AN,Mack MJ,Reynolds MR,Rumsfeld JS,Cohen DJ

    更新日期:2017-04-01 00:00:00

  • Diagnostic Accuracy of Computed Tomography-Derived Fractional Flow Reserve : A Systematic Review.

    abstract:Importance:Computed tomography-derived fractional flow reserve (FFR-CT) is a novel, noninvasive test for myocardial ischemia. Clinicians using FFR-CT must be able to interpret individual FFR-CT results to determine subsequent patient care. Objective:To provide clinicians a means of interpreting individual FFR-CT resul...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.1314

    authors: Cook CM,Petraco R,Shun-Shin MJ,Ahmad Y,Nijjer S,Al-Lamee R,Kikuta Y,Shiono Y,Mayet J,Francis DP,Sen S,Davies JE

    更新日期:2017-07-01 00:00:00

  • Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study.

    abstract:Importance:The Open-Label Study of Long-term Evaluation Against LDL-C (OSLER-1) evaluated the durability of long-term efficacy and safety during long-term therapy with evolocumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9). Objective:To determine whether LDL-C level reductions ...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.0747

    authors: Koren MJ,Sabatine MS,Giugliano RP,Langslet G,Wiviott SD,Kassahun H,Ruzza A,Ma Y,Somaratne R,Raal FJ

    更新日期:2017-06-01 00:00:00

  • Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.

    abstract:Importance:Persons with human immunodeficiency virus (HIV) that is treated with antiretroviral therapy have improved longevity but face an elevated risk of myocardial infarction (MI) due to common MI risk factors and HIV-specific factors. Despite these elevated MI rates, optimal methods to predict MI risks for HIV-infe...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2016.4494

    authors: Feinstein MJ,Nance RM,Drozd DR,Ning H,Delaney JA,Heckbert SR,Budoff MJ,Mathews WC,Kitahata MM,Saag MS,Eron JJ,Moore RD,Achenbach CJ,Lloyd-Jones DM,Crane HM

    更新日期:2017-02-01 00:00:00

  • Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals.

    abstract:Importance:Cardiac resynchronization therapy (CRT) provides significant reduction in morbidity and mortality in select patients with left ventricular systolic dysfunction and specific parameters of electrocardiographic evidence of dyssynchrony. Relative to the 2012 American College of Cardiology/American Heart Associat...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.1755

    authors: Sandhu A,Bao H,Minges KE,Varosy PD,Borne RT,Zipse MM,Marzec L,Peterson P,Masoudi F,Bradley SM

    更新日期:2019-08-01 00:00:00

  • Long-term Outcomes Associated With Total Arterial Revascularization vs Non-Total Arterial Revascularization.

    abstract:Importance:The optimal conduits for coronary artery bypass grafting (CABG) remain controversial in multivessel coronary artery disease. Objective:To compare the long-term clinical outcomes of total arterial revascularization (TAR) vs non-TAR (CABG with at least 1 arterial and 1 saphenous vein graft) in a multicenter p...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2019.6104

    authors: Rocha RV,Tam DY,Karkhanis R,Wang X,Austin PC,Ko DT,Gaudino M,Royse A,Fremes SE

    更新日期:2020-05-01 00:00:00

  • Sex Differences in Blood Pressure Trajectories Over the Life Course.

    abstract:Importance:If we assume that women and men exhibit variations of the same fundamental vascular physiology, then conventional analyses of subclinical measures would suggest that women catch up to men by midlife in the extent of potentially important vascular disease. Alternatively, under the assumption that vascular phy...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.5306

    authors: Ji H,Kim A,Ebinger JE,Niiranen TJ,Claggett BL,Bairey Merz CN,Cheng S

    更新日期:2020-03-01 00:00:00

  • Outpatient Worsening Heart Failure as a Target for Therapy: A Review.

    abstract:Importance:Hospitalizations for worsening heart failure (WHF) represent an enormous public health and financial burden, with physicians, health systems, and payers placing increasing emphasis on hospitalization prevention. In addition, maximizing time out of the hospital is an important patient-centered outcome. In thi...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.5250

    authors: Greene SJ,Mentz RJ,Felker GM

    更新日期:2018-03-01 00:00:00

  • Sudden Cardiac Arrest Risk Assessment: Population Science and the Individual Risk Mandate.

    abstract:Importance:High-resolution stratification of risk of sudden cardiac arrest (SCA) in individual patients is a tool that is necessary for achieving effective and efficient application of data generated by population-based research. This concept is at the core of initiatives for merging cost effectiveness with maximized c...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,评审

    doi:10.1001/jamacardio.2017.0266

    authors: Myerburg RJ,Goldberger JJ

    更新日期:2017-06-01 00:00:00

  • Myocarditis in Duchenne Muscular Dystrophy After Changing Steroids.

    abstract:Importance:Cardiac dysfunction is a leading cause of morbidity and mortality in Duchenne muscular dystrophy (DMD). This case highlights the importance of steroids in treating cardiac complications of DMD and the dangers of discontinuing or switching between steroid classes. Objective:To recognize the presentation of a...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2018.2695

    authors: Abutaleb ARA,McNally EM,Khan SS,Anderson AS,Carr JC,Wilcox JE

    更新日期:2018-10-01 00:00:00

  • Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition.

    abstract:Importance:Low-density lipoprotein cholesterol (LDL-C) is an important modifiable risk factor for atherosclerotic cardiovascular disease. It is unclear whether the percentage LDL-C lowering with pharmacotherapies differs on the basis of baseline LDL-C levels. Objective:To evaluate the association between baseline LDL-...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.6184

    authors: Marcusa DP,Giugliano RP,Park JG,de Lemos JA,Cannon CP,Sabatine MS

    更新日期:2020-11-13 00:00:00

  • Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.

    abstract:Importance:The period following heart failure hospitalization (HFH) is a vulnerable time with high rates of death or recurrent HFH. Objective:To evaluate clinical characteristics, outcomes, and treatment response to vericiguat according to prespecified index event subgroups and time from index HFH in the Vericiguat Gl...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2020.6455

    authors: Lam CSP,Giczewska A,Sliwa K,Edelmann F,Refsgaard J,Bocchi E,Ezekowitz JA,Hernandez AF,O'Connor CM,Roessig L,Patel MJ,Pieske B,Anstrom KJ,Armstrong PW,VICTORIA Study Group.

    更新日期:2020-11-13 00:00:00

  • Cardiac Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome.

    abstract:Importance:Hutchinson-Gilford progeria syndrome (HGPS) is an ultrarare disorder associated with premature death due to cardiovascular events during the second decade of life. However, because of its rarity (107 identified living patients), the natural history of cardiac disease remains uncharacterized. Therefore, meani...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2017.5235

    authors: Prakash A,Gordon LB,Kleinman ME,Gurary EB,Massaro J,D'Agostino R Sr,Kieran MW,Gerhard-Herman M,Smoot L

    更新日期:2018-04-01 00:00:00

  • Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study : A Randomized Clinical Trial.

    abstract:Importance:Cohort studies have reported increased incidence of cardiovascular disease (CVD) among individuals with low vitamin D status. To date, randomized clinical trials of vitamin D supplementation have not found an effect, possibly because of using too low a dose of vitamin D. Objective:To examine whether monthly...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,随机对照试验

    doi:10.1001/jamacardio.2017.0175

    authors: Scragg R,Stewart AW,Waayer D,Lawes CMM,Toop L,Sluyter J,Murphy J,Khaw KT,Camargo CA Jr

    更新日期:2017-06-01 00:00:00

  • Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.

    abstract:Importance:Racial differences are recognized in multiple cardiovascular parameters, including left ventricular hypertrophy and heart failure, which are 2 major manifestations of hypertrophic cardiomyopathy. The association of race with disease expression and outcomes among patients with hypertrophic cardiomyopathy is n...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.4638

    authors: Eberly LA,Day SM,Ashley EA,Jacoby DL,Jefferies JL,Colan SD,Rossano JW,Semsarian C,Pereira AC,Olivotto I,Ingles J,Seidman CE,Channaoui N,Cirino AL,Han L,Ho CY,Lakdawala NK

    更新日期:2020-01-01 00:00:00

  • Resuscitation Practices Associated With Survival After In-Hospital Cardiac Arrest: A Nationwide Survey.

    abstract:IMPORTANCE:Although survival of patients with in-hospital cardiac arrest varies markedly among hospitals, specific resuscitation practices that distinguish sites with higher cardiac arrest survival rates remain unknown. OBJECTIVE:To identify resuscitation practices associated with higher rates of in-hospital cardiac a...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.0073

    authors: Chan PS,Krein SL,Tang F,Iwashyna TJ,Harrod M,Kennedy M,Lehrich J,Kronick S,Nallamothu BK,American Heart Association's Get With the Guidelines–Resuscitation Investigators.

    更新日期:2016-05-01 00:00:00

  • Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.

    abstract:Importance:Improvements in symptoms, functional capacity, and quality of life are among the key goals of edge-to-edge transcatheter mitral valve repair (TMVR) for mitral regurgitation. Objective:To examine health status outcomes among patients undergoing TMVR in clinical practice and the factors associated with improv...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamacardio.2018.3359

    authors: Arnold SV,Li Z,Vemulapalli S,Baron SJ,Mack MJ,Kosinski AS,Reynolds MR,Hermiller JB,Rumsfeld JS,Cohen DJ

    更新日期:2018-12-01 00:00:00

  • Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.

    abstract:Importance:Limited evidence is available regarding the benefit and hazard of higher-intensity treatment to lower lipid levels among patients 75 years or older. As a result, guideline recommendations differ for this age group compared with younger patients. Objective:To determine the effect on outcomes and risks of com...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1001/jamacardio.2019.2306

    authors: Bach RG,Cannon CP,Giugliano RP,White JA,Lokhnygina Y,Bohula EA,Califf RM,Braunwald E,Blazing MA

    更新日期:2019-09-01 00:00:00

  • Adjunctive Antithrombotic Therapy for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.

    abstract:Importance:Transcatheter aortic valve replacement (TAVR) is an established alternative to surgery for patients with severe symptomatic aortic stenosis. Adjunctive antithrombotic therapy used to mitigate thrombotic risks in patients undergoing TAVR must be balanced against bleeding complications, since both are associat...

    journal_title:JAMA cardiology

    pub_type: 杂志文章,评审

    doi:10.1001/jamacardio.2019.4367

    authors: Saito Y,Nazif T,Baumbach A,Tchétché D,Latib A,Kaple R,Forrest J,Prendergast B,Lansky A

    更新日期:2020-01-01 00:00:00

  • Association of Blood Pressure Patterns in Young Adulthood With Cardiovascular Disease and Mortality in Middle Age.

    abstract:Importance:Determining blood pressure (BP) patterns in young adulthood that are associated with cardiovascular disease (CVD) events in later life may help to identify young adults who have an increased risk for CVD. Objective:To determine whether the long-term variability of BP across clinical visits and the rate of c...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.5682

    authors: Yano Y,Reis JP,Lewis CE,Sidney S,Pletcher MJ,Bibbins-Domingo K,Navar AM,Peterson ED,Bancks MP,Kanegae H,Gidding SS,Muntner P,Lloyd-Jones DM

    更新日期:2020-04-01 00:00:00

  • Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study.

    abstract:IMPORTANCE:Dyslipidemia in young adults in the United States during their childbearing years is common, and the consequences for the next generation are poorly understood. Further understanding of the harmful consequences of elevated low-density lipoprotein cholesterol (LDL-C) levels in young adults may help to inform ...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2015.0304

    authors: Mendelson MM,Lyass A,O'Donnell CJ,D'Agostino RB Sr,Levy D

    更新日期:2016-04-01 00:00:00

  • Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.

    abstract:Importance:There are major gaps in use of guideline-directed medical therapy (GDMT) for patients with heart failure (HF). Patient-reported data outlining patient goals and preferences associated with GDMT are not available. Objective:To survey patients with chronic HF to better understand their experiences and percept...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2019.4987

    authors: Samsky MD,Lin L,Greene SJ,Lippmann SJ,Peterson PN,Heidenreich PA,Laskey WK,Yancy CW,Greiner MA,Hardy NC,Kavati A,Park S,Mentz RJ,Fonarow GC,O'Brien EC

    更新日期:2020-03-01 00:00:00

  • Rates of Invasive Management of Cardiogenic Shock in New York Before and After Exclusion From Public Reporting.

    abstract:IMPORTANCE:Reduced rates of cardiac catheterization, percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) are an unintended consequence of public reporting of cardiogenic shock outcomes in New York. OBJECTIVES:To evaluate whether the referral rates for cardiac catheterization, PCI, or CABG...

    journal_title:JAMA cardiology

    pub_type: 杂志文章

    doi:10.1001/jamacardio.2016.0785

    authors: Bangalore S,Guo Y,Xu J,Blecker S,Gupta N,Feit F,Hochman JS

    更新日期:2016-09-01 00:00:00